PMV Pharmaceuticals Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for PMV Pharmaceuticals stock have an average target of 5.33, with a low estimate of 5.00 and a high estimate of 6.00. The average target predicts an increase of 384.55% from the current stock price of 1.10.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$5.33	$5.00	$6.00
Change	+354.55%	+384.55%	+354.55%	+445.45%

Analyst Ratings

The average analyst rating for PMV Pharmaceuticals stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	4	4	4	4	4	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+354.55%	Mar 20, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+354.55%	Aug 20, 2024
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+354.55%	May 30, 2024
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+354.55%	May 14, 2024
Albert Lowe Craig-Hallum	Craig-Hallum	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+445.45%	May 13, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 140.83M

Revenue Next Year

n/a

EPS This Year

-1.57

from -1.14

EPS Next Year

-1.68

from -1.57

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	-	49.36M	76.22M	140.83M
Revenue Growth	-	-	-	54.44%	84.76%	-	-	-
EPS	-2.40	-1.28	-1.61	-1.44	-1.14	-1.57	-1.68	-1.36
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	7	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	72.7M
Avg	n/a	n/a	49.4M
Low	n/a	n/a	31.5M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.17	-1.26	-1.03
Avg	-1.57	-1.68	-1.36
Low	-1.70	-1.92	-1.74

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.